The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients. (Q53175932)

12 May 2018

title

The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients. (English)

1 reference

12 May 2018

author name string

Catherine C Parker

1

1 reference

12 May 2018

Roger H Kim

2

1 reference

12 May 2018

Benjamin D L Li

3

1 reference

12 May 2018

Quyen D Chu

4

1 reference

12 May 2018

publication date

3 April 2012

1 reference

12 May 2018

Journal of Surgical Oncology

published in

1 reference

12 May 2018

volume

106

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

393-398

1 reference

12 May 2018

Global cancer statistics, 2002

cites work

1 reference

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

Predicting axillary nodal positivity in 2282 patients with breast carcinoma

21 January 2018

1 reference

Chemokine receptors: multifaceted therapeutic targets

21 January 2018

1 reference

The multifaceted roles of chemokines in malignancy

21 January 2018

1 reference

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

21 January 2018

1 reference

Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma

21 January 2018

1 reference

The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer

21 January 2018

1 reference

CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo

21 January 2018

1 reference

CXCR4 regulates growth of both primary and metastatic breast cancer

21 January 2018

1 reference

Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer

21 January 2018

1 reference

Validation of UBE2C protein as a prognostic marker in node-positive breast cancer

21 January 2018

1 reference

Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up

21 January 2018

1 reference

BCIRG 001 molecular analysis: prognostic factors in node-positive breast cancer patients receiving adjuvant chemotherapy.

21 January 2018

1 reference

Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen

21 January 2018

1 reference

Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: a validation study.

21 January 2018

1 reference

High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome

21 January 2018

1 reference

Triple-negative breast cancers are increased in black women regardless of age or body mass index

21 January 2018

1 reference

African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics

21 January 2018

1 reference

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States

21 January 2018

1 reference

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23113

1 reference

12 May 2018

PubMed ID

22473623

1 reference

12 May 2018